HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Bulk glycerin import alert

This article was originally published in The Rose Sheet

Executive Summary

Bulk glycerin import alert: FDA import alert on bulk glycerin from China issued Aug. 1. The agency announced the importance of increased surveillance of the substance following June reports of several instances where acetaminophen elixir products containing glycerin from China were contaminated with diethylene glycol, an anti-freeze ingredient. The contaminated product killed 30 children and poisoned 40 in Haiti. Bulk glycerin from other sources where there may be a potential for transshipment from China also may be checked for the contaminant, the alert says. Glycerin is used in a number of products including glycerin lozenges and suppositories, soaps and moisturizer in cosmetics, the alert notes. No shipments of glycerin from China have been made to the U.S. in 1996, according to U.S. Customs Service data. The alert also says that the USP identification test for glycerin will not verify the presence of diethylene glycol, recommending another method available through FDA's Division of Field Science...
UsernamePublicRestriction

Register

RS003060

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel